Oxonian Ventures
Venture capitalPalo Alto Β· Pre-SeedβSeed
Investment thesis
Oxonian Ventures focuses on early-stage investing in startups founded by Oxford University alumni. The firm aims to let Oxford alumni participate in building the future of Oxford innovation, offering an early-stage investing opportunity exclusive to Oxford graduates while targeting attractive returns. It backs ventures founded by Oxonians and draws its capital from a community of accredited investors who studied at Oxford. Founders seeking funding apply through an application form, and prospective investors who are Oxford alumni can express interest to learn more.
Source: firm website, verified Aug 3, 2026.
What they invest in
from 15 of 53 portfolio companiesAI & Machine Learning Γ8Healthtech Γ7Biotech Γ6Digital Health Γ3Enterprise Software Γ3Fintech Γ3Impact & Social Good Γ3Medical Devices Γ3
HQs:United StatesΓ11United KingdomΓ3
Investments Β· 53 tracked
founders shown can be your intro path
AOA Dx develops a blood-based liquid biopsy platform using mass spectrometry and machine learning to detect ovarian cancer at early stages through tumor-associated biomarkers in serum.
AI & Machine LearningBiotechDigital HealthHealthtechMedical DevicesDenver, US
Oriana Papin-Zoghbi(Founder)inAlex Fisher(Founder/COO)inAnna Jeter(Founder)inAlexander James Fisher(Executive Officer)Anna Milik Jeter(Executive Officer)Abigail James Mcelhinny(Executive Officer)
Apero is a healthcare software platform that provides scheduling, visit notes, revenue cycle management, patient billing, prescriptions, and financial reporting for medical practices.
HealthtechSaaSSan Francisco, US
Conductor develops AI algorithms and control software for quantum computing, helping researchers and engineers optimize qubit architectures and scaling in semiconductor-based quantum systems.
Advanced ManufacturingAI & Machine LearningDeep TechQuantum ComputingSan Francisco, US
Brandon Severin(Co-Founder & CEO)inJoel Pendleton(Co-Founder and CTO)in
Granza Bio develops immunotherapy treatments leveraging naturally-occurring attack particles that are released from cytotoxic immune cells to target diseases including cancers, autoimmunity, and infections.
BiotechDeep TechDigital HealthHealthtechSan Francisco, US
Prof. DustinAshwin Nandakumar(Founder)inAshwin Jainarayanan(Founder)in
Washington, US
Paul Patrick Winters(Director)Andrew Patrick Byrnes(Director)Adam Patrick Carte(Director)Sean Patrick Murphy(Executive Officer, Director)
Probably Genetic operates a platform for diagnosing genetic diseases, providing comprehensive genetic data and testing to patients and healthcare providers.
AI & Machine LearningBiotechDigital HealthHealthtechMedical DevicesSan Francisco, US
Lukas Lange(Founder)in
Valink Therapeutics develops bispecific antibody-drug conjugates (ADCs) for therapeutic applications, combining high-throughput discovery, antibody engineering, and medicinal chemistry capabilities.
AI & Machine LearningBiotechHealthtechMedical DevicesBoston, US
OpenSponsorship operates a digital marketplace that connects professional athletes with brands seeking authentic sponsorship partnerships.
B2B MarketplacesCreator EconomyMarketing TechMarketplacesSports Tech
Ishveen Jolly(CEO)Ron Nesbitt(Co-founder)
Frequently asked questions
- What stage does Oxonian Ventures invest at?
- Oxonian Ventures invests at the Pre-Seed, Seed stages.
- What sectors does Oxonian Ventures focus on?
- Oxonian Ventures focuses on Sector Agnostic.
- Where is Oxonian Ventures located?
- Oxonian Ventures is headquartered in Palo Alto, US.
- Does Oxonian Ventures lead rounds?
- Oxonian Ventures typically participates in rounds rather than leading them.
Images
Similar investors
AirTree Ventures runs the Pioneers community, a program supporting women and gender-diverse operators, founders and aspiring founders working in high-growth startups, offering mentorship, events and access to the AirTree team.
B Capital Group is a multi-stage venture capital firm that backs founders across the company-building lifecycle, investing in technology, healthcare, and energy & resilience sectors.
Clear Ventures is an early-stage venture capital firm that provides seed capital, connections, and company-building support to fast-growing startups.
DCVC (Data Collective) is a venture capital firm that backs founders building companies which apply technology to major challenges across areas such as energy, biotech, agriculture, and machine learning.
Felicis Ventures is an early-stage venture capital firm that has backed founders for over 20 years, leading or co-leading the majority of its investments across seed and Series A rounds.